Join
Live feed
·
NEWSReleasevia Quantisnow
Virios Therapeutics Inc. logo

Virios Therapeutics shares are trading higher after the company announced the Bateman Horne Center completed enrollment in its investigator-initiated, proof of concept LC study.

ByQuantisnow·Wall Street's wire, on your screen.
VIRI· Virios Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VIRI (Virios Therapeutics Inc.) and more on Quantisnow.

Virios Therapeutics shares are trading higher after the company announced the Bateman Horne Center completed enrollment in its investigator-initiated, proof of concept LC study. | Quantisnow